Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Chronic Disease Management Therapeutics and Device Technologies Market to reach USD 22.92 billion by the end of 2030.

Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030

Product Code: HLSDT-86859339
Publish Date: 20-05-2023
Page: 200

Global Chronic Disease Management Therapeutics and Device Technologies Market is valued at approximately USD 20.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% over the forecast period 2023-2030. The global chronic disease management therapeutics and device technologies market can be defined as the market for products and services that are used in the treatment and management of chronic diseases, such as diabetes, cardiovascular disease, cancer, respiratory disease, and others. This includes pharmaceuticals, medical devices, and other healthcare technologies that are designed to improve patient outcomes and quality of life by managing the symptoms and complications associated with chronic diseases. The driving factors for the Global Chronic Disease Management Therapeutics and Device Technologies Market are the growing prevalence of chronic diseases, growing geriatric population and rising healthcare expenditure. Moreover, increasing demand for innovative therapies and advances in medical technology is creating lucrative growth opportunities for the market over the forecast period 2023-2030.

The Global Burden of Disease study estimated that in 2020, 1.7 billion people worldwide had at least one chronic disease, and 415 million had multiple chronic diseases. The global burden of chronic diseases is increasing, with conditions such as diabetes, cardiovascular disease, cancer, and respiratory disease affecting a growing number of people worldwide. This is driving demand for new and effective treatments and management strategies. For instance, in 2021, the International Diabetes Federation (IDF) reported that the global prevalence of diabetes had risen to 10.5% among adults, up from 9.3% in 2019. This represents an estimated 463 million adults living with diabetes worldwide. Similarly, according to the American Cancer Society, the global cancer burden is expected to rise to 29.5 million new cases annually by 2040, up from an estimated 19.3 million new cases in 2020. This represents an increase of more than 50% in just 20 years. However, the high cost of Chronic Disease Management Therapeutics and Device Technologies stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Chronic Disease Management Therapeutics and Device Technologies Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the dominating market for chronic disease management therapeutics and device technologies, accounting for a significant share of the global market. The region’s strong healthcare infrastructure, high healthcare spending, and favorable reimbursement policies are driving the market growth. The Asia Pacific region is the fastest growing region in the chronic disease management therapeutics and device technologies market in the coming years. Factors driving market growth include the growing population, rising healthcare spending, and increasing prevalence of chronic diseases.

Major market player included in this report are:
Medtronic plc
Novo Nordisk A/S
Abbott Laboratories
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Johnson & Johnson Consumer Inc.
Sanofi S.A.
Dexcom, Inc.
AstraZeneca plc
Becton, Dickinson and Company (BD)

Recent Developments in the Market:
Ø In September 2020, Medtronic launched its MiniMed 770G insulin pump system, which uses advanced algorithms to automatically adjust insulin delivery to help people with diabetes better manage their blood sugar levels.
Ø In June 2020, Abbott received FDA clearance for its FreeStyle Libre 2 continuous glucose monitoring system, which allows people with diabetes to monitor their glucose levels without the need for fingerstick.
Global Chronic Disease Management Therapeutics and Device Technologies Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Disease, Therapy, Device, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Disease offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease:
Cardiovascular diseases (CVD)
Diabetes
Cancer
Chronic respiratory diseases
Chronic kidney diseases
Neurological disorders
Others (such as autoimmune diseases, gastrointestinal disorders, and many)
By Therapy:
Medications
Rehabilitation therapy
Behavioral therapy
Others (such as gene therapy, stem cell therapy, and many)
By Device:
Blood glucose monitoring devices
Blood pressure monitors
Cardiac monitors
Respiratory therapy devices
Kidney dialysis machines
Neurostimulation devices
Others (such as insulin pumps, continuous glucose monitoring devices, and many)

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Chronic Disease Management Therapeutics and Device Technologies Market, by Region, 2020-2030 (USD Billion)
1.2.2. Chronic Disease Management Therapeutics and Device Technologies Market, by Disease, 2020-2030 (USD Billion)
1.2.3. Chronic Disease Management Therapeutics and Device Technologies Market, by Therapy, 2020-2030 (USD Billion)
1.2.4. Chronic Disease Management Therapeutics and Device Technologies Market, by Device, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Chronic Disease Management Therapeutics and Device Technologies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Chronic Disease Management Therapeutics and Device Technologies Market Dynamics
3.1. Chronic Disease Management Therapeutics and Device Technologies Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of chronic diseases
3.1.1.2. Growing Geriatric Population
3.1.1.3. Rising healthcare expenditure
3.1.2. Market Challenges
3.1.2.1. High Cost of Chronic Disease Management Therapeutics and Device Technologies
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for innovative therapies
3.1.3.2. Advances in medical technology
Chapter 4. Global Chronic Disease Management Therapeutics and Device Technologies Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Disease
5.1. Market Snapshot
5.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Disease, Performance – Potential Analysis
5.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Disease 2020-2030 (USD Billion)
5.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
5.4.1. Cardiovascular diseases (CVD)
5.4.2. Diabetes
5.4.3. Cancer
5.4.4. Chronic respiratory diseases
5.4.5. Chronic kidney diseases
5.4.6. Neurological disorders
5.4.7. Others (such as autoimmune diseases, gastrointestinal disorders, and many)
Chapter 6. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Therapy
6.1. Market Snapshot
6.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Therapy, Performance – Potential Analysis
6.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Therapy 2020-2030 (USD Billion)
6.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
6.4.1. Medications
6.4.2. Rehabilitation therapy
6.4.3. Behavioral therapy
6.4.4. Others (such as gene therapy, stem cell therapy, and many)
Chapter 7. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Device
7.1. Market Snapshot
7.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Device, Performance – Potential Analysis
7.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Device 2020-2030 (USD Billion)
7.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
7.4.1. Blood glucose monitoring devices
7.4.2. Blood pressure monitors
7.4.3. Cardiac monitors
7.4.4. Respiratory therapy devices
7.4.5. Kidney dialysis machines
7.4.6. Neurostimulation devices
7.4.7. Others (such as insulin pumps, continuous glucose monitoring devices, and many)
Chapter 8. Global Chronic Disease Management Therapeutics and Device Technologies Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Chronic Disease Management Therapeutics and Device Technologies Market, Regional Market Snapshot
8.4. North America Chronic Disease Management Therapeutics and Device Technologies Market
8.4.1. U.S. Chronic Disease Management Therapeutics and Device Technologies Market
8.4.1.1. Disease breakdown estimates & forecasts, 2020-2030
8.4.1.2. Therapy breakdown estimates & forecasts, 2020-2030
8.4.1.3. Device breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Chronic Disease Management Therapeutics and Device Technologies Market
8.5. Europe Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
8.5.1. U.K. Chronic Disease Management Therapeutics and Device Technologies Market
8.5.2. Germany Chronic Disease Management Therapeutics and Device Technologies Market
8.5.3. France Chronic Disease Management Therapeutics and Device Technologies Market
8.5.4. Spain Chronic Disease Management Therapeutics and Device Technologies Market
8.5.5. Italy Chronic Disease Management Therapeutics and Device Technologies Market
8.5.6. Rest of Europe Chronic Disease Management Therapeutics and Device Technologies Market
8.6. Asia-Pacific Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
8.6.1. China Chronic Disease Management Therapeutics and Device Technologies Market
8.6.2. India Chronic Disease Management Therapeutics and Device Technologies Market
8.6.3. Japan Chronic Disease Management Therapeutics and Device Technologies Market
8.6.4. Australia Chronic Disease Management Therapeutics and Device Technologies Market
8.6.5. South Korea Chronic Disease Management Therapeutics and Device Technologies Market
8.6.6. Rest of Asia Pacific Chronic Disease Management Therapeutics and Device Technologies Market
8.7. Latin America Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
8.7.1. Brazil Chronic Disease Management Therapeutics and Device Technologies Market
8.7.2. Mexico Chronic Disease Management Therapeutics and Device Technologies Market
8.8. Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market
8.8.1. Saudi Arabia Chronic Disease Management Therapeutics and Device Technologies Market
8.8.2. South Africa Chronic Disease Management Therapeutics and Device Technologies Market
8.8.3. Rest of Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Medtronic plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Novo Nordisk A/S
9.3.3. Abbott Laboratories
9.3.4. F. Hoffmann-La Roche Ltd
9.3.5. GlaxoSmithKline plc
9.3.6. Johnson & Johnson Consumer Incd
9.3.7. Sanofi S.A.
9.3.8. Dexcom, Inc.
9.3.9. AstraZeneca plc
9.3.10. Becton, Dickinson and Company (BD)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now